Remi A Nout, MD, PhD

Remi Nout currently heads the Department of Radiotherapy at the Erasmus Medical Center, Rotterdam, The Netherlands. He is well known for his role in PORTEC trials investigating the role of radiotherapy in endometrial cancer. He has actively contributed to the coordinator role in the EMBRACE group, which focuses on the role of image-guided radiotherapy and brachytherapy for cervical cancer. He co-led a multicenter international BIOEMBRACE study that tested the impact of biomarkers in cervical cancer. He is principal investigator of new studies that combine image-guided adaptive brachytherapy with immunotherapy and targeted therapies in high-risk cervical cancer, the EMBRAVE study in primary and recurrent vaginal cancers, and the RAPID prospective study in low-risk cervical cancer, which will test the role of de-escalation in cervical cancer. He co-leads RetroCOSMOS, an international registry for recurrent metastatic cervical cancer, with a focus on re-irradiation. He is currently a co-chair of the ESTRO Gynec Focus group and chair of the Dutch Gynaecological Oncology Group (DGOG) and Gynecological Cancer Inter Group – Cervical Cancer Research Network (GCIG-CCRN); radiotherapy representative in the European Society of Gynaecological Oncology (ESGO) council, and has been involved in European multidisciplinary guidelines for cervical, endometrial, and vaginal cancers. He has actively contributed to international education and training as co-course director of the ESTRO Gyn course and through collaborations within AROI-ESTRO, IGCS, and CCRN training programs.